Drosophila SETs its sights on cancer: Trr/MLL3/4 COMPASS-like complexes in development and disease.

The COMPASS family, which functions in the regulation of developmental gene expression, is a group of histone H3 lysine 4 (H3K4) methylases that is evolutionarily conserved from Saccharomyces cerevisiae (yeast) to human (1). Although there is only one Set1/COMPASS in yeast, Drosophila cells possess three yeast Set1-related proteins: dSet1, Trithorax (Trx), and Trithorax-related (Trr), all found within COMPASS-like compositions (1). Mammalian cells possess two representatives for each of the three subclasses found in Drosophila for a total of six COMPASS family members: SET1A and SET1B (related to dSet1); MLL1 and MLL2 (related to Trx); and MLL3 and MLL4 (related to Trr). Expansion of this family over evolutionary time implies a diversification in the function of H3K4 methylation, and studies into the distinct roles of the different branches of the COMPASS family support this notion. Drosophila and mammalian Set1 complexes mediate the bulk of genomic H3K4 diand trimethylation (2–4). In contrast, the Trx/MLL1/2 complexes act in a highly gene-specific manner, in particular, controlling expression of distinct homeotic genes, including those within the Hox gene clusters (1, 5). MLL1 has been extensively studied in mouse models and human cells, as MLL1 translocations cause aggressive infant leukemias (6–8). Trr/ MLL3/4 complexes are involved in nuclear hormone receptor signaling in both Drosophila and mammals (9, 10), and inactivating mutations have recently been implicated in human cancer (11– 16). Mammalian MLL3/4 are large proteins (approximately 5,000 amino acids), whereas Drosophila Trr is homologous to the carboxy-terminal PHD, FYRN, FYRC, and SET domain of MLL3/4. A separate gene, LPT (Lost PHDs of Trr), encodes a protein homologous to the MLL3/4 amino terminus (3, 17). Moreover, Trr and LPT associate in the same complex, suggesting that a gene fission event had occurred in an ancestral gene in the Drosophila lineage (3). Set1/COMPASS in yeast is unique in its ability to mono-, di-, and trimethylate its nucleosomal substrate (1, 18). The pattern of localization of histone H3K4 trimethylation (H3K4me3) and COMPASS on chromatin was first demonstrated to strongly correlate with transcriptionally active promoters in yeast (19), and this role of H3K4me3 in marking actively transcribed genes is highly conserved across the eukaryotes and is indeed used as a landmark for finding active promoters (20, 21). In contrast to H3K4me3, H3K4 monomethylation (H3K4me1) is found on poised and/or active enhancers (22, 23). Given that there are six COMPASS family members in mammalian cells, it was not clear until recently which COMPASS family member is involved in implementing H3K4me1 on enhancers. Recent work has now uncovered an unexpected role for Trr/MLL3/4 in gene regulation through enhancer-promoter communication. It was demonstrated that Trr functions as a major H3K4 monomethylase targeting enhancers in Drosophila (24). Moreover, loss of Trr impairs long-range enhancer function during Drosophila wing development. Given the strong association of H3K4me1 with enhancers (22) and the emerging connections between MLL3/4 and human disease, the relationship between Trr/MLL3/4 methylase activity and gene regulation is an area of burgeoning interest. In this issue, Kanda and coworkers from the Hariharan laboratory (25) report the use of elegant genetic tools in Drosophila to shed light on Trr function during development and draw a striking parallel between Drosophila Trr and MLL3/4 mutations in human cancer. Using genetic mosaics, Kanda et al. demonstrate that during Drosophila eye development, cells lacking Trr have a clonal growth advantage over their wild-type counterparts. In agreement with recent work identifying Trr as a major H3K4 monomethylase involved in enhancer function (24), they observed a dramatic loss of H3K4me1 in trr mutant tissue accompanied by altered activity of key developmental signaling pathways, namely, Notch, Dpp/BMP, and receptor tyrosine kinases (RTK). In stark contrast to the growth advantage conferred by Trr deficiency, Trx mutant clones fail to proliferate and display increased apoptosis, mirroring the phenotypes observed in mammalian Mll1/2 loss-of-function studies (26, 27). Quite remarkably, these distinct Trx (growth-promoting) versus Trr (growth-suppressing) functions may be conserved in mammals. Mll1 knockout mice lack hematopoetic stem cells and display embryonic proliferation defects, whereas gain-of-function Mll1 fusions cause aggressive leukemia (6, 27, 28). Similarly, Mll2 mutant embryos are severely growth retarded at early developmental stages and display widespread apoptosis (26). In contrast, mice lacking the Mll3 SET domain are viable but develop ureteric tumors, demonstrating a tumor suppressor function (29). Moreover, a series of genome-wide studies have identified loss-of-function mutations in MLL3 and MLL4 and in their cofactor, UTX, in diverse human cancers (11–16). Consistent with this, Drosophila Utx mutant clones also display an overgrowth phenotype (30). As for many of the Drosophila trr alleles characterized by the Hariharan laboratory, many cancer-associated MLL3 and MLL4 mutations result in truncation of point mutations in the catalytic SET domain (Fig. 1). Intriguingly, chromatin profiling in human cancer suggests a key role for H3K4me1. The genome-wide distribution of H3K4me1 undergoes a consistent alteration in colon cancer, often resulting in the loss of intestinal crypt-specific H3K4me1 marks (31). Collectively, these data provide evidence